Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
pluripotent stem cell-derived mesenchymal stem cell exosome
- Development stage
- Phase 2
- Lead developer
- Cells for Cells
- Modality
- iPSCs → Pluripotent Stem Cells → Stem Cell Therapies → Cell Therapies, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Intravenous, Intramuscular, Topical, Ophthalmic, Subcutaneous, Intradermal, Intraarticular
01
Overview
Pluripotent stem cell-derived mesenchymal stem cell exosomes are extracellular vesicles (EVs) secreted by mesenchymal stem cells (MSCs) that have been differentiated from induced pluripotent stem cells (iPSCs). These exosomes are nanosized vesicles with a lipid bilayer membrane, typically ranging from 30 to 200 nm in diameter. They contain proteins, lipids, RNA molecules (including microRNAs and mRNAs), and other bioactive molecules derived from their parental cells[1][2][4]. The primary mechanism of action involves intercellular communication through the transfer of these bioactive cargoes to recipient cells, modulating cellular behavior and promoting tissue repair and regeneration. Exosomes derived from iPSC-MSCs have shown therapeutic potential in various injury models by promoting angiogenesis, reducing inflammation, and enhancing wound healing[2][4]. Their use is considered a non-cell-based therapy approach in regenerative medicine.
- Other names
- iPSC-MSC exosomeinduced pluripotent stem cell-derived mesenchymal stem cell exosomeiMSC exosome
Beyond the preview
Go deeper on pluripotent stem cell-derived mesenchymal stem cell exosome.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on pluripotent stem cell-derived mesenchymal stem cell exosome.